chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 39.0
Sex: M
Vaccine: COVID19
Symptoms: Asthenia, Spontaneous penile erection
Clinical narrative: Erection; Low energy; This spontaneous case was reported by a consumer and describes the occurrence of SPONTANEOUS PENILE ERECTION (Erection) and ASTHENIA (Low energy) in a 39-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 04-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 04-Mar-2021, the patient experienced SPONTANEOUS PENILE ERECTION (Erection) and ASTHENIA (Low energy). On 05-Mar-2021, ASTHENIA (Low energy) had resolved. On 06-Mar-2021, SPONTANEOUS PENILE ERECTION (Erection) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications were reported.  No treatment information was provided.
Age: 68.0
Sex: F
Vaccine: COVID19
Symptoms: Discomfort, Paraesthesia
Clinical narrative: concerned about receiving the 2nd dose; tingling all over her body day"; This spontaneous case was reported by a consumer and describes the occurrence of PARAESTHESIA (tingling all over her body day") and DISCOMFORT (concerned about receiving the 2nd dose) in a 68-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 016M20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 11-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 12-Feb-2021, the patient experienced PARAESTHESIA (tingling all over her body day"). On 08-Mar-2021, the patient experienced DISCOMFORT (concerned about receiving the 2nd dose). At the time of the report, PARAESTHESIA (tingling all over her body day") and DISCOMFORT (concerned about receiving the 2nd dose) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No relevant concomitant medications were reported. No treatment information was provided.
Age: 89.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity
Clinical narrative: A little arm soreness; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (A little arm soreness) in an 89-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 002A21A) for COVID-19 vaccination.     Concurrent medical conditions included Depression. Concomitant products included SERTRALINE HYDROCHLORIDE (ZOLOFT) and MENTHOL (BIOFREEZE PAIN RELIEVING) for an unknown indication.   On 25-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (A little arm soreness). At the time of the report, PAIN IN EXTREMITY (A little arm soreness) outcome was unknown.            Concomitants were provided blood pressure medication. thyroid medication and cholesterol medication.   Reporter did not allow further contact
Age: 74.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Fatigue, Feeling abnormal, Myalgia, Nausea
Clinical narrative: Not feeling by herself; Very Achy; Very Tired; Extreme thirst; Extremely chilly; Very nauseous throughout the day; A spontaneous report was received from a consumer concerning a 73-years-old female patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced events extremely chilly, very nauseous throughout the day, very achy, very tired, not feeling by herself, extreme thirst.  The patient's medical history was not provided. No relevant concomitant medications were reported.  On 6 Mar 2021, prior to the onset of the events the patient received first of two planned doses of mRNA-1273 (lot/batch: 001A21A) intramuscularly in the left arm for prophylaxis of COVID-19 infection.  On 6 Mar 2021, the patient experienced the events  extremely chilly, very nauseous throughout the day. On 7 Mar 2021, the patient experienced the events  very achy, very tired. On 8 Mar 2021, the patient experienced the events not feeling by herself, extreme thirst. She consented for follow up with safety. She agreed on follow up with her health care provider. Treatment details included None.  Action taken with mRNA-1273 in response to the events was not reported.   The outcome of events, extremely chilly, very nauseous throughout the day, very achy, very tired, not feeling by herself, extreme thirst was unknown.
Age: 74.0
Sex: F
Vaccine: COVID19
Symptoms: Thirst
Clinical narrative: Not feeling by herself; Very Achy; Very Tired; Extreme thirst; Extremely chilly; Very nauseous throughout the day; A spontaneous report was received from a consumer concerning a 73-years-old female patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced events extremely chilly, very nauseous throughout the day, very achy, very tired, not feeling by herself, extreme thirst.  The patient's medical history was not provided. No relevant concomitant medications were reported.  On 6 Mar 2021, prior to the onset of the events the patient received first of two planned doses of mRNA-1273 (lot/batch: 001A21A) intramuscularly in the left arm for prophylaxis of COVID-19 infection.  On 6 Mar 2021, the patient experienced the events  extremely chilly, very nauseous throughout the day. On 7 Mar 2021, the patient experienced the events  very achy, very tired. On 8 Mar 2021, the patient experienced the events not feeling by herself, extreme thirst. She consented for follow up with safety. She agreed on follow up with her health care provider. Treatment details included None.  Action taken with mRNA-1273 in response to the events was not reported.   The outcome of events, extremely chilly, very nauseous throughout the day, very achy, very tired, not feeling by herself, extreme thirst was unknown.
Age: 81.0
Sex: M
Vaccine: COVID19
Symptoms: Abdominal pain upper, Arthralgia, Bedridden, Chills, Decreased appetite
Clinical narrative: Stomach pain; Has not eaten anything; Could not get out of bed; Shaking; Headache; Muscle pain; Joint pain; Chills; Fatigue; Slight fever; This spontaneous case was reported by a consumer and describes the occurrence of ABDOMINAL PAIN UPPER (Stomach pain), DECREASED APPETITE (Has not eaten anything), BEDRIDDEN (Could not get out of bed), TREMOR (Shaking) and HEADACHE (Headache) in an 81-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025A121A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included COVID-19 in March 2020.    On 02-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced ABDOMINAL PAIN UPPER (Stomach pain), DECREASED APPETITE (Has not eaten anything), BEDRIDDEN (Could not get out of bed), TREMOR (Shaking), HEADACHE (Headache), MYALGIA (Muscle pain), ARTHRALGIA (Joint pain), CHILLS (Chills), FATIGUE (Fatigue) and PYREXIA (Slight fever). The patient was treated with IBUPROFEN (ADVIL [IBUPROFEN]) for Adverse event, at a dose of UNK dosage form. At the time of the report, ABDOMINAL PAIN UPPER (Stomach pain), DECREASED APPETITE (Has not eaten anything), BEDRIDDEN (Could not get out of bed), TREMOR (Shaking), HEADACHE (Headache), MYALGIA (Muscle pain), ARTHRALGIA (Joint pain), CHILLS (Chills), FATIGUE (Fatigue) and PYREXIA (Slight fever) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications reported.   This case was linked to MOD-2021-035030 (E2B Linked Report).
Age: 81.0
Sex: M
Vaccine: COVID19
Symptoms: Fatigue, Headache, Myalgia, Pyrexia, Tremor
Clinical narrative: Stomach pain; Has not eaten anything; Could not get out of bed; Shaking; Headache; Muscle pain; Joint pain; Chills; Fatigue; Slight fever; This spontaneous case was reported by a consumer and describes the occurrence of ABDOMINAL PAIN UPPER (Stomach pain), DECREASED APPETITE (Has not eaten anything), BEDRIDDEN (Could not get out of bed), TREMOR (Shaking) and HEADACHE (Headache) in an 81-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025A121A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included COVID-19 in March 2020.    On 02-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced ABDOMINAL PAIN UPPER (Stomach pain), DECREASED APPETITE (Has not eaten anything), BEDRIDDEN (Could not get out of bed), TREMOR (Shaking), HEADACHE (Headache), MYALGIA (Muscle pain), ARTHRALGIA (Joint pain), CHILLS (Chills), FATIGUE (Fatigue) and PYREXIA (Slight fever). The patient was treated with IBUPROFEN (ADVIL [IBUPROFEN]) for Adverse event, at a dose of UNK dosage form. At the time of the report, ABDOMINAL PAIN UPPER (Stomach pain), DECREASED APPETITE (Has not eaten anything), BEDRIDDEN (Could not get out of bed), TREMOR (Shaking), HEADACHE (Headache), MYALGIA (Muscle pain), ARTHRALGIA (Joint pain), CHILLS (Chills), FATIGUE (Fatigue) and PYREXIA (Slight fever) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications reported.   This case was linked to MOD-2021-035030 (E2B Linked Report).
Age: 58.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Chills, Fatigue, Headache, Injection site erythema
Clinical narrative: fever; chills; taste ot metallic; headache; tiredness; soreness; red raised injection site; This spontaneous case was reported by an other health care professional and describes the occurrence of PYREXIA (fever), CHILLS (chills), TASTE DISORDER (taste ot metallic), HEADACHE (headache) and FATIGUE (tiredness) in a 58-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event.    On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 2 dosage form. On an unknown date, the patient experienced PYREXIA (fever), CHILLS (chills), TASTE DISORDER (taste ot metallic), HEADACHE (headache), FATIGUE (tiredness), ARTHRALGIA (soreness) and INJECTION SITE ERYTHEMA (red raised injection site). At the time of the report, PYREXIA (fever), CHILLS (chills), TASTE DISORDER (taste ot metallic), HEADACHE (headache), FATIGUE (tiredness), ARTHRALGIA (soreness) and INJECTION SITE ERYTHEMA (red raised injection site) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant medications was not reported  Treatment information was not reported
Age: 58.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia, Taste disorder
Clinical narrative: fever; chills; taste ot metallic; headache; tiredness; soreness; red raised injection site; This spontaneous case was reported by an other health care professional and describes the occurrence of PYREXIA (fever), CHILLS (chills), TASTE DISORDER (taste ot metallic), HEADACHE (headache) and FATIGUE (tiredness) in a 58-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event.    On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 2 dosage form. On an unknown date, the patient experienced PYREXIA (fever), CHILLS (chills), TASTE DISORDER (taste ot metallic), HEADACHE (headache), FATIGUE (tiredness), ARTHRALGIA (soreness) and INJECTION SITE ERYTHEMA (red raised injection site). At the time of the report, PYREXIA (fever), CHILLS (chills), TASTE DISORDER (taste ot metallic), HEADACHE (headache), FATIGUE (tiredness), ARTHRALGIA (soreness) and INJECTION SITE ERYTHEMA (red raised injection site) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant medications was not reported  Treatment information was not reported
Age: 63.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Headache, Nasopharyngitis, Pyrexia, Somnolence
Clinical narrative: COVID symptoms; cold; low grade fever of 99 something; headache; falling asleep; exhausted; This spontaneous case was reported by a consumer and describes the occurrence of SUSPECTED COVID-19 (COVID symptoms), NASOPHARYNGITIS (cold), SOMNOLENCE (falling asleep), FATIGUE (exhausted) and PYREXIA (low grade fever of 99 something) in a 63-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. Uknown) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 15-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 15-Feb-2021, the patient experienced SOMNOLENCE (falling asleep) and FATIGUE (exhausted). On 16-Feb-2021, the patient experienced SUSPECTED COVID-19 (COVID symptoms), NASOPHARYNGITIS (cold), PYREXIA (low grade fever of 99 something) and HEADACHE (headache). On 17-Feb-2021, SUSPECTED COVID-19 (COVID symptoms), NASOPHARYNGITIS (cold), SOMNOLENCE (falling asleep), FATIGUE (exhausted), PYREXIA (low grade fever of 99 something) and HEADACHE (headache) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were reported. No treatment information was provided.
Age: 63.0
Sex: F
Vaccine: COVID19
Symptoms: Suspected COVID-19
Clinical narrative: COVID symptoms; cold; low grade fever of 99 something; headache; falling asleep; exhausted; This spontaneous case was reported by a consumer and describes the occurrence of SUSPECTED COVID-19 (COVID symptoms), NASOPHARYNGITIS (cold), SOMNOLENCE (falling asleep), FATIGUE (exhausted) and PYREXIA (low grade fever of 99 something) in a 63-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. Uknown) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 15-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 15-Feb-2021, the patient experienced SOMNOLENCE (falling asleep) and FATIGUE (exhausted). On 16-Feb-2021, the patient experienced SUSPECTED COVID-19 (COVID symptoms), NASOPHARYNGITIS (cold), PYREXIA (low grade fever of 99 something) and HEADACHE (headache). On 17-Feb-2021, SUSPECTED COVID-19 (COVID symptoms), NASOPHARYNGITIS (cold), SOMNOLENCE (falling asleep), FATIGUE (exhausted), PYREXIA (low grade fever of 99 something) and HEADACHE (headache) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were reported. No treatment information was provided.
Age: 52.0
Sex: F
Vaccine: COVID19
Symptoms: Contusion, Haematoma
Clinical narrative: bruise on left leg about the size of quarter and reddish blue in color; feels lump under the bruise; This spontaneous case was reported by a consumer and describes the occurrence of CONTUSION (bruise on left leg about the size of quarter and reddish blue in color) and HAEMATOMA (feels lump under the bruise) in a 52-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 08-Mar-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. In March 2021, the patient experienced CONTUSION (bruise on left leg about the size of quarter and reddish blue in color) and HAEMATOMA (feels lump under the bruise). At the time of the report, CONTUSION (bruise on left leg about the size of quarter and reddish blue in color) and HAEMATOMA (feels lump under the bruise) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications reported.  Treatment medications was not provided by the reporter
Age: 76.0
Sex: M
Vaccine: COVID19
Symptoms: Rash
Clinical narrative: had a general itchy rash; This spontaneous case was reported by a consumer and describes the occurrence of RASH (had a general itchy rash) in a 76-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 14-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 19-Feb-2021, the patient experienced RASH (had a general itchy rash). At the time of the report, RASH (had a general itchy rash) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were reported. No treatment information was provided.
Age: 59.0
Sex: U
Vaccine: COVID19
Symptoms: Eye irritation, Injection site pain, Vitreous floaters
Clinical narrative: Eye burning; Feeling of particle floating in eye.; Pain at injection site; This spontaneous case was reported by a consumer and describes the occurrence of EYE IRRITATION (Eye burning), VITREOUS FLOATERS (Feeling of particle floating in eye.) and INJECTION SITE PAIN (Pain at injection site) in a 59-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 003A21A) for COVID-19 vaccination.     The patient's past medical history included Heart attack in 2017.    On 05-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced EYE IRRITATION (Eye burning), VITREOUS FLOATERS (Feeling of particle floating in eye.) and INJECTION SITE PAIN (Pain at injection site). At the time of the report, EYE IRRITATION (Eye burning), VITREOUS FLOATERS (Feeling of particle floating in eye.) and INJECTION SITE PAIN (Pain at injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medication was provided.
Sex: F
Vaccine: COVID19
Symptoms: Diarrhoea
Clinical narrative: terrible diarrhea; This spontaneous case was reported by a consumer and describes the occurrence of DIARRHOEA (terrible diarrhea) in an 84-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 06-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 06-Mar-2021, the patient experienced DIARRHOEA (terrible diarrhea). On 08-Mar-2021, DIARRHOEA (terrible diarrhea) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medication reported   No treatment medication reported
Sex: F
Vaccine: COVID19
Symptoms: Wrong schedule
Clinical narrative: Unable to take second shot as advised by physician; This spontaneous case was reported by a consumer and describes the occurrence of WRONG SCHEDULE (Unable to take second shot as advised by physician) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included COPD.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-Mar-2021, the patient experienced WRONG SCHEDULE (Unable to take second shot as advised by physician). On 05-Mar-2021, WRONG SCHEDULE (Unable to take second shot as advised by physician) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment details included On antibiotics for COPD. No relevant concomitant medications were reported.; Sender's Comments: This report refers to a case of wrong technique in product usage process for mRNA-1273 with no associated AEs.
Age: 38.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Headache, Illness, Injection site urticaria, Nausea
Clinical narrative: red raised wett at injection site; tender; caused her unable to work; Headache; nausea; run down; This spontaneous case was reported by an other health care professional and describes the occurrence of INJECTION SITE URTICARIA (red raised wett at injection site), TENDERNESS (tender), ILLNESS (caused her unable to work), HEADACHE (Headache) and NAUSEA (nausea) in a 38-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Drug allergy (Amoxicillin, Vioxx, Celexa) and Adhesive tape use.    On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced INJECTION SITE URTICARIA (red raised wett at injection site), TENDERNESS (tender), ILLNESS (caused her unable to work), HEADACHE (Headache), NAUSEA (nausea) and FATIGUE (run down). At the time of the report, INJECTION SITE URTICARIA (red raised wett at injection site), TENDERNESS (tender), ILLNESS (caused her unable to work), HEADACHE (Headache), NAUSEA (nausea) and FATIGUE (run down) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No relevant concomitant medications were reported. No treatment details were reported.   Action taken with mRNA-1273 in response to the event was not applicable.
Age: 38.0
Sex: F
Vaccine: COVID19
Symptoms: Tenderness
Clinical narrative: red raised wett at injection site; tender; caused her unable to work; Headache; nausea; run down; This spontaneous case was reported by an other health care professional and describes the occurrence of INJECTION SITE URTICARIA (red raised wett at injection site), TENDERNESS (tender), ILLNESS (caused her unable to work), HEADACHE (Headache) and NAUSEA (nausea) in a 38-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Drug allergy (Amoxicillin, Vioxx, Celexa) and Adhesive tape use.    On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced INJECTION SITE URTICARIA (red raised wett at injection site), TENDERNESS (tender), ILLNESS (caused her unable to work), HEADACHE (Headache), NAUSEA (nausea) and FATIGUE (run down). At the time of the report, INJECTION SITE URTICARIA (red raised wett at injection site), TENDERNESS (tender), ILLNESS (caused her unable to work), HEADACHE (Headache), NAUSEA (nausea) and FATIGUE (run down) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No relevant concomitant medications were reported. No treatment details were reported.   Action taken with mRNA-1273 in response to the event was not applicable.
Age: 32.0
Sex: F
Vaccine: COVID19
Symptoms: Maternal exposure during pregnancy
Clinical narrative: Pregnant patient received 1st dose of the Moderna vaccine; This spontaneous prospective pregnancy case was reported by a consumer and describes the occurrence of MATERNAL EXPOSURE DURING PREGNANCY (Pregnant patient received 1st dose of the Moderna vaccine) in a 32-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 029A21A) for COVID-19 immunization.     Concomitant products included LAMOTRIGINE and BUPROPION for an unknown indication.    On 04-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. The patient's last menstrual period was on 12-Oct-2020 and the estimated date of delivery was 19-Jul-2021. On 04-Mar-2021, the patient experienced MATERNAL EXPOSURE DURING PREGNANCY (Pregnant patient received 1st dose of the Moderna vaccine). The patient received mRNA-1273 (Moderna COVID-19 Vaccine) beginning around the  twentieth week of the pregnancy.  On 04-Mar-2021, MATERNAL EXPOSURE DURING PREGNANCY (Pregnant patient received 1st dose of the Moderna vaccine) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment medications were not reported.
Age: 68.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site erythema, Vaccination site pain, Vaccination site pruritus
Clinical narrative: Upper right arm has itchines; Burning sensation on upper right arm; Upper right arm has redness; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE ERYTHEMA (Upper right arm has redness), VACCINATION SITE PRURITUS (Upper right arm has itchines) and VACCINATION SITE PAIN (Burning sensation on upper right arm) in a 68-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 00A42A) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 27-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 08-Mar-2021, the patient experienced VACCINATION SITE ERYTHEMA (Upper right arm has redness) and VACCINATION SITE PAIN (Burning sensation on upper right arm). On an unknown date, the patient experienced VACCINATION SITE PRURITUS (Upper right arm has itchines). At the time of the report, VACCINATION SITE ERYTHEMA (Upper right arm has redness), VACCINATION SITE PRURITUS (Upper right arm has itchines) and VACCINATION SITE PAIN (Burning sensation on upper right arm) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were reported. No treatment information was provided.
Sex: M
Vaccine: COVID19
Symptoms: Accidental underdose
Clinical narrative: Received a dose that was too small; This spontaneous case was reported by a consumer and describes the occurrence of ACCIDENTAL UNDERDOSE (Received a dose that was too small) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced ACCIDENTAL UNDERDOSE (Received a dose that was too small). At the time of the report, ACCIDENTAL UNDERDOSE (Received a dose that was too small) had resolved.            Treatment and concomitant medications were not provided by reporter.; Sender's Comments: This report refers to a case of Accidental Overdose for mRNA-1273 (Lot number: Unknown) with no associated AEs
Age: 75.0
Sex: F
Vaccine: COVID19
Symptoms: Erythema, Pruritus
Clinical narrative: Itching & redness on both arms and face; Beet red face & arms; Itching redness on palms & backs of hands; Itching redness on palms & backs of hands; This spontaneous case was reported by a consumer and describes the occurrence of PRURITUS (Itching redness on palms & backs of hands), ERYTHEMA (Itching redness on palms & backs of hands), PRURITUS (Itching & redness on both arms and face) and ERYTHEMA (Beet red face & arms) in a 75-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. unknown) for COVID-19 vaccination.     Previously administered products included for historical  Vaccine: Pneumovax. Past adverse reactions to the above products included Influenza with Pneumovax. Concurrent medical conditions included Penicillin allergy, Drug allergy and Asthma chronic.    On 03-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 03-Mar-2021, the patient experienced PRURITUS (Itching redness on palms & backs of hands) and ERYTHEMA (Itching redness on palms & backs of hands). On 07-Mar-2021, the patient experienced PRURITUS (Itching & redness on both arms and face) and ERYTHEMA (Beet red face & arms). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) at an unspecified dose and frequency and OMALIZUMAB (XOLAIR) at an unspecified dose and frequency. On 03-Mar-2021, PRURITUS (Itching redness on palms & backs of hands) and ERYTHEMA (Itching redness on palms & backs of hands) had resolved. On 07-Mar-2021, PRURITUS (Itching & redness on both arms and face) and ERYTHEMA (Beet red face & arms) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medication was provided. No treatment medication was provided.
Sex: F
Vaccine: COVID19
Symptoms: Chills, Malaise, Pyrexia
Clinical narrative: did not feel well; Chills; fever; This spontaneous case was reported by a consumer and describes the occurrence of MALAISE (did not feel well), CHILLS (Chills) and PYREXIA (fever) in a 67-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 003A21A and 013L20A) for COVID-19 vaccination.     The patient's past medical history included COVID-19 in December 2020.   On 03-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 01-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 01-Mar-2021, the patient experienced MALAISE (did not feel well), CHILLS (Chills) and PYREXIA (fever). At the time of the report, MALAISE (did not feel well) and PYREXIA (fever) outcome was unknown and CHILLS (Chills) had not resolved.            No concomitant medications were reported.   No treatment information was provided.   This case was linked to MOD-2021-027691 (Patient Link).
Age: 69.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site pruritus, Vaccination site rash
Clinical narrative: rash at the injection site; very itchy; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE RASH (rash at the injection site) and VACCINATION SITE PRURITUS (very itchy) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 010A21A and 018B21A) for COVID-19 vaccination.     The patient's past medical history included Thyroid disorder in 2012. Concurrent medical conditions included Drug allergy (Sulfa). Concomitant products included LEVOTHYROXINE SODIUM (SYNTHROID) and VITAMIN D NOS for an unknown indication.   On 28-Feb-2021 at 11:00 AM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 28-Mar-2021 at 11:00 AM, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 09-Mar-2021, the patient experienced VACCINATION SITE PRURITUS (very itchy). On 11-Mar-2021, the patient experienced VACCINATION SITE RASH (rash at the injection site). On 12-Mar-2021, VACCINATION SITE RASH (rash at the injection site) had resolved. At the time of the report, VACCINATION SITE PRURITUS (very itchy) had not resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Benadryl, Cholesterol and Prilosec used as a Treatment medication.   Most recent FOLLOW-UP information incorporated above includes: On 04-May-2021: follow up received on 04-May-2021 included 2nd dose information, patient details like Hight, weight and rash, provided Allergy (Sulfa), patient med History (thyroid), mention the Concomitant drug details, change the events date ( rash - Initial date-08-Mar-2021-Not recovered and rash- Initial date- 11-Mar-2021 outcome Recovered on date 12-mar-2021.)
Age: 85.0
Sex: M
Vaccine: COVID19
Symptoms: Fatigue, Herpes zoster, Vaccination site pruritus
Clinical narrative: shingles; really tired; itching at the injection site; This spontaneous case was reported by a consumer and describes the occurrence of HERPES ZOSTER (shingles), FATIGUE (really tired) and VACCINATION SITE PRURITUS (itching at the injection site) in an 85-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 15-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced HERPES ZOSTER (shingles), FATIGUE (really tired) and VACCINATION SITE PRURITUS (itching at the injection site). At the time of the report, HERPES ZOSTER (shingles), FATIGUE (really tired) and VACCINATION SITE PRURITUS (itching at the injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were reported. No treatment information was provided.
Age: 75.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity
Clinical narrative: Arm soreness; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Arm soreness) in a 75-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 029L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 26-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 26-Feb-2021, the patient experienced PAIN IN EXTREMITY (Arm soreness). At the time of the report, PAIN IN EXTREMITY (Arm soreness) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.        Concomitant medications were not reported. No treatment information was provided.    This case was linked to MOD-2021-036614 (Patient Link).
Age: 78.0
Sex: F
Vaccine: COVID19
Symptoms: Blood pressure abnormal, Blood pressure increased, Blood pressure measurement, Fall, Pyrexia
Clinical narrative: Low high blood pressure; fever; High bloosd pressre; Fell forward; This spontaneous case was reported by a consumer and describes the occurrence of BLOOD PRESSURE ABNORMAL (Low high blood pressure), PYREXIA (fever), BLOOD PRESSURE INCREASED (High bloosd pressre) and FALL (Fell forward) in a 78-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012A21A) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 03-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 03-Mar-2021, the patient experienced FALL (Fell forward). On 04-Mar-2021, the patient experienced BLOOD PRESSURE ABNORMAL (Low high blood pressure), PYREXIA (fever) and BLOOD PRESSURE INCREASED (High bloosd pressre). At the time of the report, BLOOD PRESSURE ABNORMAL (Low high blood pressure), PYREXIA (fever), BLOOD PRESSURE INCREASED (High bloosd pressre) and FALL (Fell forward) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Blood pressure measurement: 212/101 (High) high, 199/91 (High) high, 192/92 (High) high, 140/68 (High) dropped in the middle of the day and 177/90 (High) high.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Age: 77.0
Sex: F
Vaccine: COVID19
Symptoms: Cold sweat, Feeling hot, Hot flush, Hyperhidrosis
Clinical narrative: HOT FLASHES; COLD ON OUTSIDE; HOT ON INSIDE; SWEATING; This spontaneous case was reported by a consumer and describes the occurrence of HOT FLUSH (HOT FLASHES), COLD SWEAT (COLD ON OUTSIDE), FEELING HOT (HOT ON INSIDE) and HYPERHIDROSIS (SWEATING) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 013L20A and 016M20A) for COVID-19 vaccination.     No Medical History information was reported.   On 22-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 19-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced HOT FLUSH (HOT FLASHES), COLD SWEAT (COLD ON OUTSIDE), FEELING HOT (HOT ON INSIDE) and HYPERHIDROSIS (SWEATING). At the time of the report, HOT FLUSH (HOT FLASHES), COLD SWEAT (COLD ON OUTSIDE), FEELING HOT (HOT ON INSIDE) and HYPERHIDROSIS (SWEATING) outcome was unknown.            No relevant concomitant medications were reported. No treatment information was provided.
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Chills, Dizziness, Headache, Heart rate increased
Clinical narrative: headache; chills; joint pain; nausea; dizziness; fast heartbeat at night; Swelling around injection site; Rash at injection site that is now gone; Redness around injection site; This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE (headache), CHILLS (chills), ARTHRALGIA (joint pain), NAUSEA (nausea) and DIZZINESS (dizziness) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 06-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced HEADACHE (headache), CHILLS (chills), ARTHRALGIA (joint pain), NAUSEA (nausea), DIZZINESS (dizziness), HEART RATE INCREASED (fast heartbeat at night), VACCINATION SITE SWELLING (Swelling around injection site), VACCINATION SITE RASH (Rash at injection site that is now gone) and VACCINATION SITE ERYTHEMA (Redness around injection site). At the time of the report, HEADACHE (headache), CHILLS (chills), ARTHRALGIA (joint pain), NAUSEA (nausea), DIZZINESS (dizziness), HEART RATE INCREASED (fast heartbeat at night), VACCINATION SITE SWELLING (Swelling around injection site), VACCINATION SITE RASH (Rash at injection site that is now gone) and VACCINATION SITE ERYTHEMA (Redness around injection site) outcome was unknown.            No relevant concomitant medications were reported. No treatment information was provided.
Sex: F
Vaccine: COVID19
Symptoms: Nausea, Vaccination site erythema, Vaccination site rash, Vaccination site swelling
Clinical narrative: headache; chills; joint pain; nausea; dizziness; fast heartbeat at night; Swelling around injection site; Rash at injection site that is now gone; Redness around injection site; This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE (headache), CHILLS (chills), ARTHRALGIA (joint pain), NAUSEA (nausea) and DIZZINESS (dizziness) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 06-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced HEADACHE (headache), CHILLS (chills), ARTHRALGIA (joint pain), NAUSEA (nausea), DIZZINESS (dizziness), HEART RATE INCREASED (fast heartbeat at night), VACCINATION SITE SWELLING (Swelling around injection site), VACCINATION SITE RASH (Rash at injection site that is now gone) and VACCINATION SITE ERYTHEMA (Redness around injection site). At the time of the report, HEADACHE (headache), CHILLS (chills), ARTHRALGIA (joint pain), NAUSEA (nausea), DIZZINESS (dizziness), HEART RATE INCREASED (fast heartbeat at night), VACCINATION SITE SWELLING (Swelling around injection site), VACCINATION SITE RASH (Rash at injection site that is now gone) and VACCINATION SITE ERYTHEMA (Redness around injection site) outcome was unknown.            No relevant concomitant medications were reported. No treatment information was provided.
Age: 56.0
Sex: F
Vaccine: COVID19
Symptoms: Underdose
Clinical narrative: She did not think she received the full dose/the bandage was quite moist; A spontaneous report was received from a pharmacist for a 56 year old female patient who received Moderna's COVID-19 vaccine (mRNA-1273) and it was reported that the patient did not think that she received the full dose/the bandage was quite moist.  The patient's medical history was not provided. No concomitant product use was reported.  On 19 Feb 2021, the patient received their first of two planned doses of mRNA-1273 (Lot number: 007M20A) intramuscularly in left arm for prophylaxis of COVID-19 infection.   On 19 Feb 2021, a week after administration of the vaccine, the pharmacist was made aware that the bandage was moist and the patient thought that full dose of vaccine was not administered. The patient's doctor recommended the patient to get second dose of vaccine. Treatment information was not applicable.  Action taken with mRNA-1273 was unknown.  The outcome of the event, the patient did not think that the patient received the full dose/the bandage was quite moist was considered as resolved.; Reporter's Comments: This report refers to a case of Product administration error  Underdose  for mRNA-1273, lot # 007M20A with no associated Adverse Events.
Age: 48.0
Sex: F
Vaccine: COVID19
Symptoms: Feeling abnormal, Migraine
Clinical narrative: Migraine; felt like a punch; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of MIGRAINE (Migraine) and FEELING ABNORMAL (felt like a punch) in a 48-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 013L20A and 032L20A) for COVID-19 vaccination.     Concurrent medical conditions included Myasthenia gravis.   On 22-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 20-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 20-Feb-2021, the patient experienced MIGRAINE (Migraine) and FEELING ABNORMAL (felt like a punch). At the time of the report, MIGRAINE (Migraine) had resolved and FEELING ABNORMAL (felt like a punch) outcome was unknown.            No concomitant medications were provided. Treatment medication included Aleve twice a day.   This case was linked to MOD-2021-055176 (Patient Link).; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
Age: 75.0
Sex: F
Vaccine: COVID19
Symptoms: Blood glucose, Chills, Headache, Illness, Pain
Clinical narrative: Sickness; Whole body pain; Cant raise or move arms; Symptoms of covid; Extreme headache like my head was going to crack in half; Chills; Pain in her arm; This spontaneous case was reported by a consumer and describes the occurrence of ILLNESS (Sickness), PAIN (Whole body pain), VACCINATION SITE MOVEMENT IMPAIRMENT (Cant raise or move arms), SUSPECTED COVID-19 (Symptoms of covid) and PAIN IN EXTREMITY (Pain in her arm) in a 75-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 029L20A and 029L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Diabetes.   On 26-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 05-Mar-2021, the patient experienced PAIN IN EXTREMITY (Pain in her arm). On 06-Mar-2021, the patient experienced ILLNESS (Sickness), PAIN (Whole body pain), VACCINATION SITE MOVEMENT IMPAIRMENT (Cant raise or move arms), SUSPECTED COVID-19 (Symptoms of covid), HEADACHE (Extreme headache like my head was going to crack in half) and CHILLS (Chills). The patient was treated with IBUPROFEN at an unspecified dose and frequency. At the time of the report, ILLNESS (Sickness), PAIN (Whole body pain), VACCINATION SITE MOVEMENT IMPAIRMENT (Cant raise or move arms), SUSPECTED COVID-19 (Symptoms of covid), PAIN IN EXTREMITY (Pain in her arm), HEADACHE (Extreme headache like my head was going to crack in half) and CHILLS (Chills) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Blood glucose: 562 (High) Increased.         Concomitant medications were not reported. Ibuprofen helped the patient.   This case was linked to MOD-2021-036599 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 16-Jun-2021: Follow-up received on 16-06-2021: No new information provided, Denied further contact
Age: 75.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity, Suspected COVID-19, Vaccination site movement impairment
Clinical narrative: Sickness; Whole body pain; Cant raise or move arms; Symptoms of covid; Extreme headache like my head was going to crack in half; Chills; Pain in her arm; This spontaneous case was reported by a consumer and describes the occurrence of ILLNESS (Sickness), PAIN (Whole body pain), VACCINATION SITE MOVEMENT IMPAIRMENT (Cant raise or move arms), SUSPECTED COVID-19 (Symptoms of covid) and PAIN IN EXTREMITY (Pain in her arm) in a 75-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 029L20A and 029L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Diabetes.   On 26-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 05-Mar-2021, the patient experienced PAIN IN EXTREMITY (Pain in her arm). On 06-Mar-2021, the patient experienced ILLNESS (Sickness), PAIN (Whole body pain), VACCINATION SITE MOVEMENT IMPAIRMENT (Cant raise or move arms), SUSPECTED COVID-19 (Symptoms of covid), HEADACHE (Extreme headache like my head was going to crack in half) and CHILLS (Chills). The patient was treated with IBUPROFEN at an unspecified dose and frequency. At the time of the report, ILLNESS (Sickness), PAIN (Whole body pain), VACCINATION SITE MOVEMENT IMPAIRMENT (Cant raise or move arms), SUSPECTED COVID-19 (Symptoms of covid), PAIN IN EXTREMITY (Pain in her arm), HEADACHE (Extreme headache like my head was going to crack in half) and CHILLS (Chills) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Blood glucose: 562 (High) Increased.         Concomitant medications were not reported. Ibuprofen helped the patient.   This case was linked to MOD-2021-036599 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 16-Jun-2021: Follow-up received on 16-06-2021: No new information provided, Denied further contact